BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21703180)

  • 1. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.
    Mauss S; Berger F; Filmann N; Hueppe D; Henke J; Hegener P; Athmann C; Schmutz G; Herrmann E
    J Hepatol; 2011 Dec; 55(6):1235-40. PubMed ID: 21703180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir.
    Tan LK; Gilleece Y; Mandalia S; Murungi A; Grover D; Fisher M; Atkins M; Nelson M
    J Viral Hepat; 2009 Jul; 16(7):471-8. PubMed ID: 19457140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
    Mallet V; Schwarzinger M; Vallet-Pichard A; Fontaine H; Corouge M; Sogni P; Pol S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1181-8.e1. PubMed ID: 25460550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
    Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir for the treatment of hepatitis B virus.
    Jenh AM; Thio CL; Pham PA
    Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.
    Agbaji OO; Agaba PA; Idoko JA; Taiwo B; Murphy R; Kanki P; Ekong E
    West Afr J Med; 2011; 30(3):164-8. PubMed ID: 22120479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
    Dore GJ; Cooper DA; Pozniak AL; DeJesus E; Zhong L; Miller MD; Lu B; Cheng AK; ;
    J Infect Dis; 2004 Apr; 189(7):1185-92. PubMed ID: 15031786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
    Pradat P; Le Pogam MA; Okon JB; Trolliet P; Miailhes P; Brochier C; Maynard M; Bailly F; Zoulim F; Cotte L
    J Viral Hepat; 2013 Sep; 20(9):650-7. PubMed ID: 23910650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
    Lada O; Gervais A; Branger M; Peytavin G; Roquebert B; Collin G; Fraqueiro G; Moucari R; Hamet G; Martinot-Peignoux M; Matheron S; Marcellin P
    Liver Int; 2012 Jan; 32(1):93-101. PubMed ID: 22097898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal toxicity of long-term therapy with tenofovir in HIV-infected patients.
    Monteagudo-Chu MO; Chang MH; Fung HB; Bräu N
    J Pharm Pract; 2012 Oct; 25(5):552-9. PubMed ID: 22551561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
    Matthews GV; Cooper DA; Dore GJ
    Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV-HBV-coinfected patients.
    Thibault V; Stitou H; Desire N; Valantin MA; Tubiana R; Katlama C
    Antivir Ther; 2011; 16(2):199-205. PubMed ID: 21447869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.
    Petersen J; Ratziu V; Buti M; Janssen HL; Brown A; Lampertico P; Schollmeyer J; Zoulim F; Wedemeyer H; Sterneck M; Berg T; Sarrazin C; Lutgehetmann M; Buggisch P
    J Hepatol; 2012 Mar; 56(3):520-6. PubMed ID: 22037226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tenofovir on renal glomerular and tubular function.
    Fux CA; Christen A; Zgraggen S; Mohaupt MG; Furrer H
    AIDS; 2007 Jul; 21(11):1483-5. PubMed ID: 17589197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study.
    Guaraldi G; Roverato A; Giovanardi C; Ravera F; Squillace N; Orlando G; Cappelli G; Esposito R; Palella F
    J Antimicrob Chemother; 2009 Feb; 63(2):374-9. PubMed ID: 19095683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.
    Pan CQ; Hu KQ; Yu AS; Chen W; Bunchorntavakul C; Reddy KR
    J Viral Hepat; 2012 Mar; 19(3):213-9. PubMed ID: 22329376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.